These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 9133184

  • 1. [Neostigmine and edrophonium. Antagonism of profound and shallow mivacurium blockade].
    Bartunek A, Gilly H, Huemer G, Yildiz S, Schramm W, Lackner FX, Foldes FF.
    Anaesthesist; 1997 Feb; 46(2):96-100. PubMed ID: 9133184
    [Abstract] [Full Text] [Related]

  • 2. Edrophonium antagonism of intense mivacurium-induced neuromuscular block in children.
    Abdulatif M, Al-Ghamdi A, Al-Sanabary M, Abdel-Gaffar ME.
    Br J Anaesth; 1996 Feb; 76(2):239-44. PubMed ID: 8777104
    [Abstract] [Full Text] [Related]

  • 3. Enzymatic versus pharmacologic antagonism of profound mivacurium- induced neuromuscular blockade.
    Naguib M, Selim M, Bakhamees HS, Samarkandi AH, Turkistani A.
    Anesthesiology; 1996 May; 84(5):1051-9. PubMed ID: 8623998
    [Abstract] [Full Text] [Related]

  • 4. Dose responses for neostigmine and edrophonium as antagonists of mivacurium in adults and children.
    Bevan JC, Tousignant C, Stephenson C, Blackman L, Reimer E, Smith MF, Bevan DR.
    Anesthesiology; 1996 Feb; 84(2):354-61. PubMed ID: 8602666
    [Abstract] [Full Text] [Related]

  • 5. Antagonism of mivacurium neuromuscular block: neostigmine versus edrophonium.
    Devcic A, Munshi CA, Gandhi SK, Kampine JP.
    Anesth Analg; 1995 Nov; 81(5):1005-9. PubMed ID: 7486038
    [Abstract] [Full Text] [Related]

  • 6. Edrophonium requirements for reversal of deep neuromuscular block following infusion of mivacurium.
    Miller DR, Bryson G, Martineau RJ, Kitts JB, Curran M, Bragg P, Watson JB, Hull K, Lindsay P.
    Can J Anaesth; 1995 Nov; 42(11):996-1002. PubMed ID: 8590511
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Edrophonium and human plasma cholinesterase combination for antagonism of mivacurium-induced neuromuscular block.
    Naguib M, Samarkandi AH, Bakhamees HS, Turkistani A, Alharby SW.
    Br J Anaesth; 1996 Sep; 77(3):424-6. PubMed ID: 8949825
    [Abstract] [Full Text] [Related]

  • 9. Antagonism of mivacurium-induced neuromuscular blockade in humans. Edrophonium dose requirements at threshold train-of-four count of 4.
    Kopman AF, Mallhi MU, Justo MD, Rodricks P, Neuman GG.
    Anesthesiology; 1994 Dec; 81(6):1394-400. PubMed ID: 7992908
    [Abstract] [Full Text] [Related]

  • 10. Neostigmine but not edrophonium prolongs the action of mivacurium.
    Symington MJ, Mirakhur RK, Kumar N.
    Can J Anaesth; 1996 Dec; 43(12):1220-3. PubMed ID: 8955970
    [Abstract] [Full Text] [Related]

  • 11. Antagonism of mivacurium block with edrophonium from various degrees of spontaneous recovery.
    Connolly FM, Mirakhur RK, Loan PB, McCoy EP, Symington M, Kumar N.
    Br J Anaesth; 1995 Feb; 74(2):229-30. PubMed ID: 7696074
    [Abstract] [Full Text] [Related]

  • 12. The reversal of profound mivacurium-induced neuromuscular blockade.
    Kao YJ, Le ND.
    Can J Anaesth; 1996 Nov; 43(11):1128-33. PubMed ID: 8922768
    [Abstract] [Full Text] [Related]

  • 13. Dose-response relationships for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular block.
    Naguib M, Abdulatif M, al-Ghamdi A, Hamo I, Nouheid R.
    Br J Anaesth; 1993 Nov; 71(5):709-14. PubMed ID: 8251285
    [Abstract] [Full Text] [Related]

  • 14. Recovery characteristics after early administration of anticholinesterases during intense mivacurium-induced neuromuscular block.
    Abdulatif M.
    Br J Anaesth; 1995 Jan; 74(1):20-5. PubMed ID: 7880699
    [Abstract] [Full Text] [Related]

  • 15. Recovery from mivacurium block with or without anticholinesterase following continuous infusion in obstetric patients.
    Jan GS, Tong WN, Chan AM, Hui TW, Lo JW.
    Anaesth Intensive Care; 1996 Oct; 24(5):585-9. PubMed ID: 8909671
    [Abstract] [Full Text] [Related]

  • 16. Effect of neostigmine at different levels of mivacurium-induced neuromuscular blockade.
    Trévien V, Lienhart A, Just B, Chandon M, Baras E, Camatte S.
    Acta Anaesthesiol Scand Suppl; 1995 Oct; 106():66-9. PubMed ID: 8533550
    [Abstract] [Full Text] [Related]

  • 17. Spontaneous versus edrophonium-induced recovery from paralysis with mivacurium.
    Brandom BW, Taiwo OO, Woelfel SK, Schön H, Gronert BJ, Cook DR.
    Anesth Analg; 1996 May; 82(5):999-1002. PubMed ID: 8610913
    [Abstract] [Full Text] [Related]

  • 18. [Effects of different doses of edrophonium antagonism of mivacurium-induced neuromuscular block in the presence of nitrous oxide, propofol, and alfentanil anesthesia].
    Ripart J, Drolet P, Perreault L, Girard M.
    Can J Anaesth; 1996 Apr; 43(4):368-72. PubMed ID: 8697552
    [Abstract] [Full Text] [Related]

  • 19. Dose-response relationships for edrophonium antagonism of mivacurium-induced neuromuscular block during N2O-enflurane-alfentanil anaesthesia.
    Marcotte J, Drolet P, Perreault L, Girard M.
    Can J Anaesth; 1995 Oct; 42(10):879-83. PubMed ID: 8706197
    [Abstract] [Full Text] [Related]

  • 20. Enzymatic antagonism of mivacurium-induced neuromuscular blockade by human plasma cholinesterase.
    Naguib M, Daoud W, el-Gammal M, Ammar A, Turkistani A, Selim M, Altamimi W, Sohaibani MO.
    Anesthesiology; 1995 Oct; 83(4):694-701. PubMed ID: 7574048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.